With an extensive background in pharmaceutical operations management, Jeffrey Autrey holds senior responsibilities with Sumitomo Pharma America, Inc. He directs oncology regulatory affairs and authors, prepares, and monitors investigational new drug (IND), clinical trial application (CTA), and new drug application (NDA) maintenance submissions. Working closely with team members, Jeffrey Autrey coordinates regulatory content and draws up achievable project plans and timelines. He has a strong understanding of the standards and procedures required for successful regulatory submissions.
Mr. Autrey previously served as a global submission manager in Pfizer’s global regulatory operations and assisted in the development of major markets. Active with cross-functional development teams, he defined realistic deliverable timelines and ensured adherence with global e-publishing standards.
With a background in education grant management, Mr. Autrey has provided outreach for district- and state-level competitions, within the scope of a national educational enrichment program. He is interested in philosophy and self-help, as well as art history, archaeology, and ancient history. Mr. Autrey also enjoys hiking and running 5k races.